Key result
High systolic blood pressure resulted in an age-standardized mortality rate of 153.34 per 100,000 population in China in 2019, approximately 3.5-fold higher than in Japan and South Korea.
Why the study?
Hypertension is an independent risk factor for cardiovascular disease and death, but few data were analyzed on deaths and DALYs caused by hypertension in East Asia.
Observational
While the mortality and DALY burden attributable to hypertension has declined in East Asia over the past 29 years, China retains a significantly higher and slower-declining burden compared to Japan and South Korea.
China's elevated hypertension mortality may warrant intensified control efforts; leaves open drivers of slower East Asian decline.
Background Hypertension has been confirmed as an independent risk factor for cardiovascular disease and death. Few data were analyzed on deaths and disability-adjusted life years (DALYs) caused by hypertension in East Asia. We aimed to provide an overview of burden attributable to high blood pressure in China in the past 29 years, compared with those in Japan and South Korea. Methods Data were collected from the 2019 Global Burden of Disease study on diseases due to high systolic blood pressure (SBP). We retrieved the age-standardized mortality rate (ASMR) and DALYs rate (ASDR) by gender, age, location, and sociodemographic index. The death and DALY trends were evaluated by estimated annual percentage change, with 95% confidence interval. Findings Considerable differences were detected in the diseases attributable to high SBP in China, Japan, and South Korea. In 2019, the ASMR and ASDR of diseases due to high SBP in China were 153.34 (126.19, 182.49) per 100,000 population and 2,844.27 (2,391.91, 3,321.12) per 100,000 population, respectively, which was about 3.50-fold of those in another two countries. The elders and males had higher ASMR and ASDR in the three countries. Between 1990 and 2019, the declining trends were less pronounced in China for both the deaths and DALYs. Conclusions The deaths and DALYs due to hypertension declined in China, Japan, and South Korea in the past 29 years, with China having the greatest burden.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2023) conducted an observational in Hypertension / High systolic blood pressure. High systolic blood pressure vs. Japan and South Korea was evaluated on Age-standardized mortality rate (ASMR) per 100,000 population in 2019 (95% CI 126.19-182.49). High systolic blood pressure resulted in an age-standardized mortality rate of 153.34 per 100,000 population in China in 2019, approximately 3.5-fold higher than in Japan and South Korea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: